Get startedLog in
    Picture of Kdventures AB logo

    KDV B — Kdventures AB News Story

    0.000.00%
    se flag iconLast trade - 00:00
    FinancialsSpeculativeMicro CapSucker Stock
    All News

    Brief: Karolinska Development Portfolio Company Presents Preclinical Data

    Picture of Kdventures AB logoKdventures AB
    03/01/2023 07:53
    Jan 3 (Reuters) - Karolinska Development AB  KDEV.ST :
    * KAROLINSKA DEVELOPMENT’S PORTFOLIO COMPANY UMECRINE
COGNITION
PRESENTS PRECLINICAL DATA SHOWING EFFECT OF GOLEXANOLONE IN A
PARKINSON’S DISEASE MODEL
    * RESULTS INDICATE THAT GOLEXANOLONE COULD IMPROVE SEVERAL
SYMPTOMS OF PARKINSON'S DISEASE

Source text for Eikon:  ID:nGNEqT9f9 
Further company coverage:  KDEV.ST 
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

    Recent news on Kdventures AB

    See all news